PillTablet, Extended Release
Metoprolol Succinate
Metoprolol Succinate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US11 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.089
Latest avg · Jul 22, 2026
+8%
Since Dec 17, 2025
4
Active US suppliers
64%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
36K
Rx · 2026 Q1
2.5M
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Nivagen Pharmaceuticals, Inc. | unknown | 8 | SUPPLYING |
| Dr.Reddy's laboratories Limited | unknown | 6 | SUPPLYING |
| AstraZeneca AB | unknown | 4 | SUPPLYING |
| Pharmadax Inc | unknown | 4 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Apr 23, 2018RECALLRecall (Class II): Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100 Tablets bottle, Rx only, Manufactured by: Dr. Reddy's L…
Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets. — Recalling firm: Dr. Reddy's Laboratories, Inc. — Nationwide